Medical Microbiology SBM 2044 Assoc Prof Dr Othman Abd Samah Tel : 09-5716744 Email :...
-
Upload
luke-short -
Category
Documents
-
view
215 -
download
0
Transcript of Medical Microbiology SBM 2044 Assoc Prof Dr Othman Abd Samah Tel : 09-5716744 Email :...
Medical MicrobiologySBM 2044
Assoc Prof Dr Othman Abd SamahTel : 09-5716744
Email : [email protected]
Sr. Intan Azura ShahdanTel : 09-5716400 ext 2816
Email : [email protected]
SBM 2044 LECTURE 1
INTRODUCTION TO MODULE
• Methods of assessment
• Module Aims & Objectives
• Course structure, Reading, etc.
• Introduction – Recall some foundations from Principles of Microbiology SBM 2053
Value: 4 credit hours
SBM 2044: Aims
To foster knowledge and understanding of certainmicrobial pathogens, selected to illustrate:
• various kinds of host-pathogen interactions
• experimental approaches used to study bacterial/viral pathogens
• molecular mechanisms in bacterial pathogenicity
• clinical diagnosis and treatment
Course Content
• Microbes – Man interactions Week 1-3
• Medical Bacteriology Week 4-6
• Medical Virology & Biological Agents of Warfare Week 7-10
• Medical Mycology Week 11-12
• Emerging infectious diseases Week 13
• Introduction to the diagnosis and treatment of infection Week 14
Microbes – Man interactions
Lecture 1:
• Why is this subject important?
• The normal human flora
• Introduction to bacterial pathogenesis
• Factors influencing bacterial-host interactions
Lecture 2:
Lecture 3:
• Weapons delivery and deployment
Today1. How do we recognise pathogens?
Only a tiny proportion of all known microbes cause disease
2. How do we identify a particular microbe as the cause of a particular disease?
3. Which microbes cause disease?
4. How do they do it?
5. How do we stop them?
6. How do we identify a particular microbe as the cause of a patient’s illness?
3%6%
8%
20% 63%
NutritionalInjury
Perinatal
Various Non-communicable
INFECTIOUSDISEASE
Deaths in children (0 – 4 years) in 1998
Data from WHO 1999
Vineeth, 7 months old and identified as HIV-positive, cries at the Community Health Education Society orphanage in Madras, India.
The WHO estimates 800,000 children were infected with HIV in 2001 alone, almost all through mother-to-child transmission.
NutritionalMaternal
Various non-communicable Injuries
Perinatal
INFECTIOUSDISEASE
48%19%
18%
10%3% 2%
Premature deaths (0 – 44 years) in 1998
Data from WHO 1999
Deaths 1945 – 1993 (in millions)
War
AIDS + Malaria + TB
Spending 1995(in billions $)
Military
AIDS + Malaria + TB
Human priorities ?
23
150
15
864
Malaysian Facts
• Population: 24,821,286 (July 2007 est.)• Death rate: 5.05 deaths/1,000 population
(2007 est.)• HIV/AIDS (2003 est.) –
– adult prevalence rate: 0.4% – people living with HIV/AIDS: 52,000 – HIV/AIDS - deaths: 2,000
• REFERENCE: www.cia.gov/library
How do we identify a particular microbe as the cause of a particular disease?
• The Koch Henle postulates1. Isolate the organism from every case
2. Propagate in pure culture in vitro
3. Reproduce disease by injecting the organism into a suitable recipient
4. Re-isolate the organism
• OK for major acute diseases like plaque, smallpox, typhoid..
• Pathogens vs. non-pathogens: the Normal Flora– Only a minute fraction of the organisms in the
environment cause disease.
• Isolation of an organism from a patient does not imply disease.– many different forms of association between
microbes and humans– many yet unknown, non-culturable eg. In soil,
water, extreme environments– Others colonise other living organisms,
virtually all multicellular organisms have their own normal flora, organisms with which they coexist.
Factors controlling growthFactors controlling growth
1. Nutrient availability Essential elements:
• Major: C, O, H, N, S, P, K, Mg, Ca, Fe, Na, Cl• Minor: Zn, Mn, Co, Cu
All present in vivo, but all not readily available to infecting bacteria – e.g. Fe
• Concentration in plasma ca. 20µM• Freely available: 10-18M
Pathogens• All heterotrophic (need organic C source)• Many fastidious
Factors controlling growthFactors controlling growth
2. Physical environment
Water activity (aw) - not limiting in vivo
Osmotic pressure (π) - moderate/high
Oxygen – availability depends on location in vivo
• Anaerobic Facultative or Obligate• Aerobic
• Microaerophilic
• Too high for some bacteria
Factors controlling growthFactors controlling growth
2. Physical environment – contd.
Temperature: 37ºC – little variation
pH: Mostly ca. pH 7.0 in vivo, but can vary
pathogens mesophiles
• Skin: pH 5.5
• Stomach: pH 2.0 – 5.0
Factors controlling growthFactors controlling growth
3. Competition – from normal flora
Approx. number % Total
Human
Bacteria 1014
1013
Cells occupying your space
10%
90%
NORMAL HUMAN FLORANORMAL HUMAN FLORA
Internal organs/tissues normally sterile
External surfaces & accessible ‘internal’ niches colonised by certain bacterial species – include:
• Skin
• Oral cavity
• Upper respiratory tract
• Gastroinsteinal tract
• Urogenital tract
- Nares (nostrils) & nasopharynx
• Conjunctiva (eye surface)
NORMAL HUMAN FLORANORMAL HUMAN FLORA
Site numbers of bacteria
Skin 1012
Mouth 1010
Intestines 1014
Numbers & composition varies depending on location
• May also vary at different sites on same tissue
e.g. skin - approx 2 square meters - moist areas more densely populated
Complex flora : > 200 species
NORMAL HUMAN FLORANORMAL HUMAN FLORA
Skin – dominated by:• Staphylococcus epidermidis
• 20 – 30% individuals: Staphylococcus aureus
Conjunctiva
• Numbers usually low
• Mostly S. epidermidis & certain coryneforms
• Micrococcus sp. • Coryneforms (e.g. Propionibacterium acnes)
• Occasionally S. aureus, some streptococci, Neisseria sp., Haemophilus sp
NORMAL HUMAN FLORANORMAL HUMAN FLORA
Oral cavity – multiple sp., including:
• Oral streptococci (α – haemolytic)- S. salivarius, S. mutans, S. sanguis
• Lactobacillus sp, Staphylococcus sp.• Corynebacterium sp.• Many anaerobes – esp. Bacteroides sp.
Upper respiratory tract• Nares: S. epidermidis, Corynebacteria, S. aureus (20 – 30% individuals)
• Nasopharynx: Mostly α-haemolytic streptococciother Streps., Neisseria sp.,
NORMAL HUMAN FLORANORMAL HUMAN FLORA
GI Tract – multiple sp., including for example:
• Escherichia coli & other Enterobactericeae
• Clostridium perfringens
• Enterococcus faecalis
• Bacteroides sp.
Urogenital tract:
• Antherior urethra: S. epidermidis, enteric bacteria
• Vagina: various sp., including: Lactobacillus acidophilus
reciprocalbenefit
unilateral benefit
Commensalism
Harmless
Parasitism
Mutualism
Different types of symbiotic associations
Factors controlling growthFactors controlling growth
4. Host defences – Innate and specific
Dynamic, interactions with bacteria – outcome depends on the balance
H B
Host defences
Multiple factors
Bacterial virulence
Multiple factors
Normal flora - balance in a particular host niche, but not necessarily at other sites
Pathogenicity usually a multifactorial process
Overwhelm defensesrapidly kills host
No capacityto survive in/on host
Completelyavirulent
Extremelyvirulent
VirulenceVirulence
H
B
B
H
Quantitative – extent of ability to cause disease
Compromised defencesDisease
Normal defencesNo disease
Completelyavirulent
Extremelyvirulent
H
B
B
H
Opportunistic pathogens
• Other sites are normally sterile, and the presence of bacteria suggests an infection:– Blood (septicaemia)s – Cerebrospinal fluid (meningitis)– Deep tissues (abscesses)
• The digestive tract contains large numbers of organisms – up to 1/3 of faeces can be bacteria: some anaerobes are actually oxygen-sensitive
• The vast majority of normal flora organism do not cause disease, but coexist with the host -
commensals• Much of the normal flora is actually beneficial to
the host – they can exclude pathogen, by producing antibiotics, or other bactericidal substances (bacteriocins)
• Removal of the normal flora by e.g. antibiotics can make the host much more susceptible to pathogenic organisms which would otherwise not cause disease because the normal flora will prevent them from colonising the host.
Homework
• Read about the Roles of Normal Flora
– Brooks chapter 11
OR
– Schaechter chapter 2